Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Minoxidil effectively promotes hair growth in seborrheic alopecia.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Topical 5% minoxidil is effective and safe for treating androgenetic alopecia, especially in younger patients with early-stage hair loss.

VYC-12L effectively improves skin smoothness, reduces fine lines, and boosts hydration.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

Combining microneedling with 5% minoxidil is a safe and effective treatment for female pattern hair loss, promoting significant hair regrowth.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Home-use microneedles with 5% minoxidil are safe and effective for hair growth.

3% topical minoxidil is ineffective for severe chronic alopecia areata.

Tangent screens help detect visual field defects from vigabatrin.

Combining botulinum toxin type A with Minoxidil significantly improves hair growth and patient satisfaction in male hair loss.

Oral and topical tranexamic acid effectively and safely improve melasma.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Minoxidil 5% solution quickly improves hair growth and density with minimal side effects.

The treatment was not recommended due to limited effectiveness and significant side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

The combination therapy improved severe alopecia areata in a patient after 14 days.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Provenge extends prostate cancer survival by about 4 months.